Chemoinformaics analysis of Malvidin-3,5-diglucoside
| Molecular Weight | 655.582 | nRot | 9 |
| Heavy Atom Molecular Weight | 620.302 | nRig | 29 |
| Exact Molecular Weight | 655.187 | nRing | 5 |
| Solubility: LogS | -2.206 | nHRing | 3 |
| Solubility: LogP | -0.767 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 85.4018 |
| nHD | 10 | BPOL | 47.2642 |
| QED | 0.114 |
| Synth | 4.963 |
| Natural Product Likeliness | 1.443 |
| NR-PPAR-gamma | 0.837 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.993 |
| HIA | 0.96 |
| CACO-2 | -6.473 |
| MDCK | 0.000120409 |
| BBB | 0.465 |
| PPB | 0.611915 |
| VDSS | 0.635 |
| FU | 0.390887 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.046 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.153 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.129 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.184 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.002 |
| CL | 1.789 |
| T12 | 0.509 |
| hERG | 0.021 |
| Ames | 0.388 |
| ROA | 0.029 |
| SkinSen | 0.011 |
| Carcinogencity | 0.046 |
| EI | 0.004 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.835 |
| Antiviral | Yes |
| Prediction | 0.786477 |